| Literature DB >> 17092348 |
Murilo Foppa1, Bruce B Duncan, Donna K Arnett, Emelia J Benjamin, Philip R Liebson, Teri A Manolio, Thomas N Skelton.
Abstract
BACKGROUND: Cardiovascular risk associated with diabetes may be partially attributed to left ventricular structural abnormalities. However, the relations between left ventricular structure and diabetes have not been extensively studied in African-Americans.Entities:
Mesh:
Year: 2006 PMID: 17092348 PMCID: PMC1654185 DOI: 10.1186/1476-7120-4-43
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Participant characteristics by gender
| Men (N = 514) | Women (N = 965) | |
| Age – years | 58.4 (5.8) | 58.6 (5.6) |
| Diabetes (%) | 98 (19%) | 232 (24%)† |
| Obesity (%) | 152 (30%) | 509 (53%)§ |
| Hypertension (%) | 275 (53%) | 576 (60%)† |
| Height – m | 1.76 (0.07) | 1.63 (0.06)§ |
| Body Mass Index – kg/m2 | 28.1 (4.8) | 31.2 (6.2)§ |
| Systolic Blood Pressure – mmHg | 130 (20) | 131 (20) |
| Glucose – mg/dL | 120 (57) | 122 (56) |
| Smokers (%) | 139 (27%) | 145 (15%)§ |
| Metabolic Syndrome|| (%) | 185 (36%) | 501 (52%)§ |
Expressed as N (%) or mean (standard deviation);
P values testing the difference between genders: † <0.05; ‡ <0.01; § <0.001;
|| Adapted from NCEP criteria [37].
Echocardiographic measurements and prevalences of structural abnormalities in men and women*
| Men (N = 514) | Women (N = 965) | |
| Left Ventricular Diameter Diastole – mm | 47.6 (5.7) | 45.1 (5.4)§ |
| Septum Thickness – mm | 11.9 (2.5) | 11.2 (2.2)§ |
| Posterior Wall Thickness – mm | 12.0 (2.2) | 11.2 (1.9)§ |
| Relative Wall Thickness (RWT) | 0.51 (0.13) | 0.50 (0.11) |
| Fractional Shortening (%) | 37.0 (7.3) | 40. (7.5)§ |
| LV mass – g | 218.4 (63.8) | 184.0 (54.6)§ |
| LV mass/BSA – g/m2 | 107.2 (29.7) | 97.3 (25.7)§ |
| LV mass/Height2.7 – g/m2.7 | 47.6 (14.4) | 49.1 (14.8)† |
| Unindexed LVH (38) | 59 (11.5%) | 339 (35.1%)§ |
| Height2.7 – Indexed LVH | 169 (32.9%) | 373 (38.6%)† |
| Relative Wall Thickness >= 0.45 | 332 (64.6%) | 645 (66.8%) |
*Expressed as N (%) or mean (standard deviation);
P values testing the difference between genders: † <0.05; ‡ <0.01; § <0.001;
||According to Devereux Modified Formula;
LV = Left Ventricular; BSA = Body Surface Area; LVH = LV Hypertrophy
Figure 1Prevalences of structural abnormalities. Prevalences of left ventricular hypertrophy and increased relative wall thickness in African-Americans with diabetes (black columns) and without diabetes (grey columns); P values diabetes vs. no diabetes: † <0.05; ‡ <0.01; § <0.001; NS non significant.
Crude and adjusted associations of diabetes with height-indexed left ventricular hypertrophy (LVH2.7)
| OR (95%CI) | |
| Diabetes | 2.29 (1.78–2.94) |
| Diabetes | 1.60 (1.22–2.10) |
| Diabetes | 1.49 (1.12–2.00) |
| Gender (Male) | 0.95 (0.72–1.26) |
| Obesity (BMI) | 3.63 (2.80–4.72) |
| Waist-Hip Ratio‡ | 1.55 (1.17–2.06) |
| Systolic BP‡ | 3.41 (2.59–4.48) |
* Model adjusted for gender, BMI and waist-hip ratio;
† Model adjusted for gender, BMI, waist-hip ratio, systolic blood pressure, age, total cholesterol, activity level, smoking, education level and antihypertensive medication use;
‡ 4th Quartile vs. rest of sample;
Crude and adjusted gender-specific associations of diabetes with increased left ventricular diameter and wall thickness
| Men | Women | Men | Women | |
| OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |
| Diabetes | 2.36 (1.48–3.77) | 1.31 (0.94–1.82) | 1.77 (1.13–2.79) | 2.70 (1.97–3.68) |
| Diabetes | 2.10 (1.30–3.41) | 1.01 (0.71–1.44) | 1.48 (0.93–2.37) | 2.04 (1.47–2.84) |
| Diabetes | 2.13 (1.28–3.53) | 1.02 (0.70–1.49) | 1.33 (0.81–2.18) | 1.89 (1.34–2.66) |
| BMI‡ | 1.22 (0.75–2.00) | 3.43 (2.42–4.87) | 2.58 (1.63–4.07) | 1.68 (1.27–2.23) |
| Waist-Hip Ratio‡ | 1.50 (0.90–2.50) | 0.88 (0.61–1.27) | 1.09 (0.68–1.76) | 1.85 (1.32–2.58) |
| Systolic BP‡ | 1.85 (1.16–2.96) | 2.04 (1.44–2.89) | 2.24 (1.43–3.52) | 2.00 (1.44–2.79) |
* Models adjusted for BMI, waist-hip ratio and height;
† Models adjusted for BMI, waist-hip ratio, systolic blood pressure, height, age, total cholesterol, activity level, smoking, education level and antihypertensive medication use;
‡ 4th Quartile vs. rest of sample;